Blockchain in Healthcare
The Office of the National Coordinator for Health IT (ONC) and the office of the Assistant Secretary for Planning and Evaluation (ASPE) are proud to present the 4th installment of the Interoperability in Action Webinar series, which will focus on the use of blockchain technology and its current and future implications in the healthcare field. The event will kick-off with keynote speaker Justin Herman of General Services Administration (GSA), as well as a Blockchain update presented by the National Institute of Standards and Technology (NIST). The webinar will also feature presentations from the four 1st round winners of ONC’s Health Data Provenance Challenge in which participants proposed solutions to real-world obstacles for provenance in clinical care. Of the four 1st round winners, three proposed solutions involved the use of blockchain technology. Finally, we will conclude the event with an HHS Roundtable and Q & A session.
To Join: https://cccwebinars.webex.com/cccwebinars/onstage/g.php?MTID=e0c0b0877e0b2cb0e9d9ed625138c3692
Event number: 640 625 147
Event password: W7JJEYZY
Audio conference: To receive a call back, provide your phone number when you join the event, or call the number below and enter the access code.
US Toll Free: 1-844-621-3956 US Toll+1-240-454-0887
Access code: 640 625 147
Previous events:
Facilitators: Debbie Bucci, ONC; Victoria Donovan, ONC; Ali Massihi, ONC; Joshua Williams, ASPE
Welcome and Introduction to the Webinar
- Steven Posnack, Office of the National Coordinator for Health IT
Keynote Speaker: Justin Herman, General Services Administration
Update from National Institute of Standards and Technology (NIST)
- Dylan Yaga
BREAK
Health Data Provenance Challenge – Finalist Presentations
- RAIN Live Oak Technology
- Emrify
- 1Up Health
- Hyper E-Health
HHS Roundtable and Q&A
- Jose L. Arrieta, U.S. Department of Health and Human Services (HHS)
- Darryl Burton, Office of the Regional Administrator, Centers for Medicare and Medicaid Services (CMS)
- Sean Khozin, Oncology Center of Excellence, U.S. Food and Drug Administration (FDA)